Stakeholders meeting on access to pediatric praziquantel for preventive chemotherapy
→
Europe/Zurich
In-Person
M505 (WHO Building, Geneva, Switzerland)
M505
WHO Building
20 Avenue Appia
CH1211 Geneva 27
Description
The goals of the meeting are to :
1. sensitize stakeholders to the importance of schistosomiasis in preschool children;
2. present the phase II results of Oral Dispersible Tablet (ODT) praziquantel;
3. outline the development steps towards commercial ODT praziquantel; and to
4. discuss resource mobilization for procurement and deployment of the ODTs to
treatment of young children for schistosomiasis.
Marilyne Vonlanthen, Chantal Berthoud, Lakshmi Jonnalagedda
The agenda of this meeting is empty